Purple Biotech Ownership 2024 | Who Owns Purple Biotech Now?
Institutional Ownership
0.98%
Insider Ownership
3.27%
Retail Ownership
95.75%
Institutional Holders
9.00
Purple Biotech Institutional Shareholders
Institutional Shareholders by % of Total Shares
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| ARMISTICE CAPITAL, LLC | 5.24% | 0.01% | 1,358,000 | -757,000 | -35.79% | 552,706 | Jun 30, 2024 |
| KINGSWOOD WEALTH ADVISORS, LLC | 0.80% | 0.01% | 208,060 | 21,960 | 11.80% | 84,680 | Jun 30, 2024 |
| MORGAN STANLEY | 0.78% | - | 203,000 | 66,390 | 48.60% | 82,621 | Jun 30, 2024 |
| VENTURE VISIONARY PARTNERS LLC | 0.09% | 0.00% | 22,161 | 6,608 | 42.49% | 9,020 | Jun 30, 2024 |
| VIRTU FINANCIAL LLC | 0.07% | 0.00% | 19,273 | 3,195 | 19.87% | 8,000 | Jun 30, 2024 |
| WEALTH ADVISORS OF IOWA, LLC | 0.06% | 0.00% | 14,270 | - | - | 5,808 | Jun 30, 2024 |
| HRT FINANCIAL LP | 0.05% | - | 13,739 | 13,739 | 100.00% | 5,000 | Jun 30, 2024 |
| UBS GROUP AG | 0.05% | - | 12,852 | 1,241 | 10.69% | 5,231 | Jun 30, 2024 |
| GEODE CAPITAL MANAGEMENT, LLC | 0.05% | - | 12,666 | - | - | 5,256 | Jun 30, 2024 |
| RAYMOND JAMES & ASSOCIATES | 0.04% | - | 10,000 | - | - | 4,070 | Jun 30, 2024 |
| TD WATERHOUSE CANADA INC. | 0.02% | - | 4,000 | - | - | 3,792 | Jun 30, 2024 |
| ROYAL BANK OF CANADA | 0.01% | - | 2,158 | - | - | 1,000 | Jun 30, 2024 |
| JPMORGAN CHASE & CO | 0.00% | - | 859 | - | - | 356 | Jun 30, 2024 |
| GROUP ONE TRADING, L.P. | 0.00% | - | 400 | -2,806 | -87.52% | 166,000 | Jun 30, 2024 |
| GLOBAL RETIREMENT PARTNERS, LLC | 0.00% | - | 336 | - | - | 137 | Jun 30, 2024 |
| NORTH STAR INVESTMENT MANAGEMENT CORP. | 0.00% | - | 300 | - | - | 122 | Jun 30, 2024 |
| SOUND INCOME STRATEGIES, LLC | 0.00% | - | 100 | - | - | 41 | Jun 30, 2024 |
| 0.00% | - | 51 | 51 | 100.00% | 20 | Jun 30, 2024 | |
| RHUMBLINE ADVISERS | 0.00% | - | 16 | - | - | 6 | Jun 30, 2024 |
| MILLENNIUM MANAGEMENT LLC | - | - | - | -21,438 | -100.00% | - | Jun 30, 2024 |
Purple Biotech's largest institutional shareholder is ARMISTICE CAPITAL, LLC, holding 5.24% of the company's total share outstanding, currently valued at $552.71K. The top 10 institutional shareholders own together 7.22% of the company.
Institutional Shareholders by % of Total Assets
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| KINGSWOOD WEALTH ADVISORS, LLC | 0.80% | 0.01% | 208,060 | 21,960 | 11.80% | 84,680 | Jun 30, 2024 |
| ARMISTICE CAPITAL, LLC | 5.24% | 0.01% | 1,358,000 | -757,000 | -35.79% | 552,706 | Jun 30, 2024 |
| WEALTH ADVISORS OF IOWA, LLC | 0.06% | 0.00% | 14,270 | - | - | 5,808 | Jun 30, 2024 |
| VIRTU FINANCIAL LLC | 0.07% | 0.00% | 19,273 | 3,195 | 19.87% | 8,000 | Jun 30, 2024 |
| VENTURE VISIONARY PARTNERS LLC | 0.09% | 0.00% | 22,161 | 6,608 | 42.49% | 9,020 | Jun 30, 2024 |
| HRT FINANCIAL LP | 0.05% | - | 13,739 | 13,739 | 100.00% | 5,000 | Jun 30, 2024 |
| TD WATERHOUSE CANADA INC. | 0.02% | - | 4,000 | - | - | 3,792 | Jun 30, 2024 |
| NORTH STAR INVESTMENT MANAGEMENT CORP. | 0.00% | - | 300 | - | - | 122 | Jun 30, 2024 |
| MORGAN STANLEY | 0.78% | - | 203,000 | 66,390 | 48.60% | 82,621 | Jun 30, 2024 |
| GLOBAL RETIREMENT PARTNERS, LLC | 0.00% | - | 336 | - | - | 137 | Jun 30, 2024 |
| RAYMOND JAMES & ASSOCIATES | 0.04% | - | 10,000 | - | - | 4,070 | Jun 30, 2024 |
| SOUND INCOME STRATEGIES, LLC | 0.00% | - | 100 | - | - | 41 | Jun 30, 2024 |
| UBS GROUP AG | 0.05% | - | 12,852 | 1,241 | 10.69% | 5,231 | Jun 30, 2024 |
| 0.00% | - | 51 | 51 | 100.00% | 20 | Jun 30, 2024 | |
| GROUP ONE TRADING, L.P. | 0.00% | - | 400 | -2,806 | -87.52% | 166,000 | Jun 30, 2024 |
| GEODE CAPITAL MANAGEMENT, LLC | 0.05% | - | 12,666 | - | - | 5,256 | Jun 30, 2024 |
| ROYAL BANK OF CANADA | 0.01% | - | 2,158 | - | - | 1,000 | Jun 30, 2024 |
| JPMORGAN CHASE & CO | 0.00% | - | 859 | - | - | 356 | Jun 30, 2024 |
| RHUMBLINE ADVISERS | 0.00% | - | 16 | - | - | 6 | Jun 30, 2024 |
| MILLENNIUM MANAGEMENT LLC | - | - | - | -21,438 | -100.00% | - | Jun 30, 2024 |
The largest Purple Biotech shareholder by % of total assets is KINGSWOOD WEALTH ADVISORS, LLC. The company owns 208.06K shares of Purple Biotech (PPBT), representing 0.01% of its total assets.
Institutional Buyers
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| MORGAN STANLEY | 0.78% | - | 203,000 | 66,390 | 48.60% | 82,621 | Jun 30, 2024 |
| KINGSWOOD WEALTH ADVISORS, LLC | 0.80% | 0.01% | 208,060 | 21,960 | 11.80% | 84,680 | Jun 30, 2024 |
| HRT FINANCIAL LP | 0.05% | - | 13,739 | 13,739 | 100.00% | 5,000 | Jun 30, 2024 |
| VENTURE VISIONARY PARTNERS LLC | 0.09% | 0.00% | 22,161 | 6,608 | 42.49% | 9,020 | Jun 30, 2024 |
| VIRTU FINANCIAL LLC | 0.07% | 0.00% | 19,273 | 3,195 | 19.87% | 8,000 | Jun 30, 2024 |
| UBS GROUP AG | 0.05% | - | 12,852 | 1,241 | 10.69% | 5,231 | Jun 30, 2024 |
| 0.00% | - | 51 | 51 | 100.00% | 20 | Jun 30, 2024 | |
| RHUMBLINE ADVISERS | 0.00% | - | 16 | - | - | 6 | Jun 30, 2024 |
| JPMORGAN CHASE & CO | 0.00% | - | 859 | - | - | 356 | Jun 30, 2024 |
| ROYAL BANK OF CANADA | 0.01% | - | 2,158 | - | - | 1,000 | Jun 30, 2024 |
| GEODE CAPITAL MANAGEMENT, LLC | 0.05% | - | 12,666 | - | - | 5,256 | Jun 30, 2024 |
| SOUND INCOME STRATEGIES, LLC | 0.00% | - | 100 | - | - | 41 | Jun 30, 2024 |
| RAYMOND JAMES & ASSOCIATES | 0.04% | - | 10,000 | - | - | 4,070 | Jun 30, 2024 |
| GLOBAL RETIREMENT PARTNERS, LLC | 0.00% | - | 336 | - | - | 137 | Jun 30, 2024 |
| NORTH STAR INVESTMENT MANAGEMENT CORP. | 0.00% | - | 300 | - | - | 122 | Jun 30, 2024 |
| TD WATERHOUSE CANADA INC. | 0.02% | - | 4,000 | - | - | 3,792 | Jun 30, 2024 |
| WEALTH ADVISORS OF IOWA, LLC | 0.06% | 0.00% | 14,270 | - | - | 5,808 | Jun 30, 2024 |
| GROUP ONE TRADING, L.P. | 0.00% | - | 400 | -2,806 | -87.52% | 166,000 | Jun 30, 2024 |
| MILLENNIUM MANAGEMENT LLC | - | - | - | -21,438 | -100.00% | - | Jun 30, 2024 |
| XTX TOPCO LTD | - | - | - | -29,099 | -100.00% | - | Jun 30, 2024 |
As of Jun 30 2024, Purple Biotech's largest institutional buyer is MORGAN STANLEY. The company purchased 66.39K stocks of PPBT, valued at $82.62K.
Institutional Sellers
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| ARMISTICE CAPITAL, LLC | 5.24% | 0.01% | 1,358,000 | -757,000 | -35.79% | 552,706 | Jun 30, 2024 |
| XTX TOPCO LTD | - | - | - | -29,099 | -100.00% | - | Jun 30, 2024 |
| MILLENNIUM MANAGEMENT LLC | - | - | - | -21,438 | -100.00% | - | Jun 30, 2024 |
| GROUP ONE TRADING, L.P. | 0.00% | - | 400 | -2,806 | -87.52% | 166,000 | Jun 30, 2024 |
| WEALTH ADVISORS OF IOWA, LLC | 0.06% | 0.00% | 14,270 | - | - | 5,808 | Jun 30, 2024 |
| TD WATERHOUSE CANADA INC. | 0.02% | - | 4,000 | - | - | 3,792 | Jun 30, 2024 |
| NORTH STAR INVESTMENT MANAGEMENT CORP. | 0.00% | - | 300 | - | - | 122 | Jun 30, 2024 |
| GLOBAL RETIREMENT PARTNERS, LLC | 0.00% | - | 336 | - | - | 137 | Jun 30, 2024 |
| RAYMOND JAMES & ASSOCIATES | 0.04% | - | 10,000 | - | - | 4,070 | Jun 30, 2024 |
| SOUND INCOME STRATEGIES, LLC | 0.00% | - | 100 | - | - | 41 | Jun 30, 2024 |
| GEODE CAPITAL MANAGEMENT, LLC | 0.05% | - | 12,666 | - | - | 5,256 | Jun 30, 2024 |
| ROYAL BANK OF CANADA | 0.01% | - | 2,158 | - | - | 1,000 | Jun 30, 2024 |
| JPMORGAN CHASE & CO | 0.00% | - | 859 | - | - | 356 | Jun 30, 2024 |
| RHUMBLINE ADVISERS | 0.00% | - | 16 | - | - | 6 | Jun 30, 2024 |
| 0.00% | - | 51 | 51 | 100.00% | 20 | Jun 30, 2024 | |
| UBS GROUP AG | 0.05% | - | 12,852 | 1,241 | 10.69% | 5,231 | Jun 30, 2024 |
| VIRTU FINANCIAL LLC | 0.07% | 0.00% | 19,273 | 3,195 | 19.87% | 8,000 | Jun 30, 2024 |
| VENTURE VISIONARY PARTNERS LLC | 0.09% | 0.00% | 22,161 | 6,608 | 42.49% | 9,020 | Jun 30, 2024 |
| HRT FINANCIAL LP | 0.05% | - | 13,739 | 13,739 | 100.00% | 5,000 | Jun 30, 2024 |
| KINGSWOOD WEALTH ADVISORS, LLC | 0.80% | 0.01% | 208,060 | 21,960 | 11.80% | 84,680 | Jun 30, 2024 |
As of Jun 30 2024, Purple Biotech's biggest institutional seller is ARMISTICE CAPITAL, LLC. The company sold -0.76M shares of PPBT, valued at $552.71K.
Institutional New positions
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| HRT FINANCIAL LP | 0.05% | - | 13,739 | 13,739 | 100.00% | 5,000 | Jun 30, 2024 |
| 0.00% | - | 51 | 51 | 100.00% | 20 | Jun 30, 2024 |
Purple Biotech's largest new institutional shareholder by number of shares is HRT FINANCIAL LP, purchased 13.74K shares, valued at $5.00K, as of undefined.
Institutional Sold Out
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| XTX TOPCO LTD | - | - | - | -29,099 | -100.00% | - | Jun 30, 2024 |
| MILLENNIUM MANAGEMENT LLC | - | - | - | -21,438 | -100.00% | - | Jun 30, 2024 |
Purple Biotech's largest sold out institutional shareholder by shares sold is XTX TOPCO LTD, sold -29.10K shares, valued at -, as of undefined.
Purple Biotech Mutual Fund Holders
| Name | % Total Assets | Total Shares | Change Amount | Change % | Date |
|---|---|---|---|---|---|
| Ark ETF Trust | 0.01% | 103,464 | - | - | Jan 31, 2024 |
| FIDELITY CONCORD STREET TRUST | 0.00% | 12,666 | - | - | Feb 29, 2024 |
| TRUST FOR PROFESSIONAL MANAGERS | 0.00% | 4,003 | - | - | Feb 29, 2024 |
Purple Biotech's largest mutual fund holder by % of total assets is "Ark ETF Trust", owning 103.46K shares, compromising 0.01% of its total assets.
Purple Biotech Institutional Ownership Trends
Institutional Holdings Trend
| Date | Holdings | Change % |
|---|---|---|
| 30 Jun, 24 | 9 | -59.09% |
| 31 Mar, 24 | 22 | 10.00% |
| 31 Dec, 23 | 20 | 5.26% |
| 30 Sep, 23 | 19 | - |
| 30 Jun, 23 | 19 | 5.56% |
| 31 Mar, 23 | 18 | - |
| 31 Dec, 22 | 18 | 50.00% |
| 30 Sep, 22 | 12 | -20.00% |
| 30 Jun, 22 | 15 | -11.76% |
| 31 Mar, 22 | 17 | 13.33% |
| 31 Dec, 21 | 15 | -6.25% |
| 30 Sep, 21 | 16 | -11.11% |
| 30 Jun, 21 | 18 | 5.88% |
| 31 Mar, 21 | 17 | 21.43% |
| 31 Dec, 20 | 14 | - |
As of 30 Jun 24, 9 institutions are holding Purple Biotech's shares, representing a decrease of -59.09% compared to the previous quarter.
Shares Outstanding Trend
| Date | Shares Outstanding | Change % |
|---|---|---|
| 30 Jun, 24 | 254,751 | -90.34% |
| 31 Mar, 24 | 2,637,428 | 8.39% |
| 31 Dec, 23 | 2,433,294 | 888.54% |
| 30 Sep, 23 | 246,150 | -11.26% |
| 30 Jun, 23 | 277,381 | 121.75% |
| 31 Mar, 23 | 125,087 | -27.92% |
| 31 Dec, 22 | 173,538 | 56.83% |
| 30 Sep, 22 | 110,656 | -15.16% |
| 30 Jun, 22 | 130,428 | -70.97% |
| 31 Mar, 22 | 449,213 | -57.27% |
| 31 Dec, 21 | 1,051,180 | -8.64% |
| 30 Sep, 21 | 1,150,614 | 50.88% |
| 30 Jun, 21 | 762,616 | 31.42% |
| 31 Mar, 21 | 580,296 | -46.61% |
| 31 Dec, 20 | 1,086,957 | - |
Purple Biotech (PPBT) has 254.75K shares outstanding as of 30 Jun 24, down -90.34% compared to the previous quarter.
Institutional Ownership Trend
| Date | Ownership % | Change % |
|---|---|---|
| 30 Jun, 24 | 0.98% | 0.86% |
| 31 Mar, 24 | 10.71% | 8.63% |
| 31 Dec, 23 | 11.14% | 811.54% |
| 30 Sep, 23 | 1.17% | 59.94% |
| 30 Jun, 23 | 1.40% | 351.70% |
| 31 Mar, 23 | 0.63% | 70.80% |
| 31 Dec, 22 | 0.94% | 251.72% |
| 30 Sep, 22 | 0.61% | 116.38% |
| 30 Jun, 22 | 0.73% | 11.40% |
| 31 Mar, 22 | 2.52% | 8.72% |
| 31 Dec, 21 | 5.38% | 12.46% |
| 30 Sep, 21 | 6.57% | 43.15% |
| 30 Jun, 21 | 3.90% | 34.99% |
| 31 Mar, 21 | 3.34% | 3.74% |
| 31 Dec, 20 | 9.45% | - |
As of 30 Jun 24, Purple Biotech is held by 0.98% institutional shareholders, representing a 0.86% growth compared to 31 Mar 24.
Institutional Increased Positions Trend
| Date | Increased Positions | Change % |
|---|---|---|
| 30 Jun, 24 | 2 | -81.82% |
| 31 Mar, 24 | 11 | 10.00% |
| 31 Dec, 23 | 10 | 66.67% |
| 30 Sep, 23 | 6 | -40.00% |
| 30 Jun, 23 | 10 | 66.67% |
| 31 Mar, 23 | 6 | -25.00% |
| 31 Dec, 22 | 8 | 60.00% |
| 30 Sep, 22 | 5 | -28.57% |
| 30 Jun, 22 | 7 | 75.00% |
| 31 Mar, 22 | 4 | 100.00% |
| 31 Dec, 21 | 2 | -60.00% |
| 30 Sep, 21 | 5 | -37.50% |
| 30 Jun, 21 | 8 | -20.00% |
| 31 Mar, 21 | 10 | -28.57% |
| 31 Dec, 20 | 14 | - |
2 institutional shareholders have increased their position in PPBT stock as of 30 Jun 24 compared to 11 in the previous quarter (a -81.82% decrease).
Institutional Reduced Positions Trend
| Date | Reduced Positions | Change % |
|---|---|---|
| 30 Jun, 24 | - | -100.00% |
| 31 Mar, 24 | 3 | 50.00% |
| 31 Dec, 23 | 2 | - |
| 30 Sep, 23 | 2 | - |
| 30 Jun, 23 | 2 | -50.00% |
| 31 Mar, 23 | 4 | 33.33% |
| 31 Dec, 22 | 3 | 50.00% |
| 30 Sep, 22 | 2 | 100.00% |
| 30 Jun, 22 | 1 | -83.33% |
| 31 Mar, 22 | 6 | - |
| 31 Dec, 21 | 6 | - |
| 30 Sep, 21 | 6 | 50.00% |
| 30 Jun, 21 | 4 | - |
| 31 Mar, 21 | 4 | - |
| 31 Dec, 20 | - | - |
- institutional shareholders have reduced their position in PPBT stock as of 30 Jun 24 compared to 3 in the previous quarter (a -100.00% decrease).
All Institutional Ownership Trend Data
| Date | Holdings | Change % | Shares Outstanding | Change % | Ownership % | Change % | Increased Positions | Change % | Reduced Positions | Change % |
|---|---|---|---|---|---|---|---|---|---|---|
| 30 Jun, 24 | 9 | -59.09% | 254,751 | -90.34% | 0.98% | 0.86% | 2 | -81.82% | - | -100.00% |
| 31 Mar, 24 | 22 | 10.00% | 2,637,428 | 8.39% | 10.71% | 8.63% | 11 | 10.00% | 3 | 50.00% |
| 31 Dec, 23 | 20 | 5.26% | 2,433,294 | 888.54% | 11.14% | 811.54% | 10 | 66.67% | 2 | - |
| 30 Sep, 23 | 19 | - | 246,150 | -11.26% | 1.17% | 59.94% | 6 | -40.00% | 2 | - |
| 30 Jun, 23 | 19 | 5.56% | 277,381 | 121.75% | 1.40% | 351.70% | 10 | 66.67% | 2 | -50.00% |
| 31 Mar, 23 | 18 | - | 125,087 | -27.92% | 0.63% | 70.80% | 6 | -25.00% | 4 | 33.33% |
| 31 Dec, 22 | 18 | 50.00% | 173,538 | 56.83% | 0.94% | 251.72% | 8 | 60.00% | 3 | 50.00% |
| 30 Sep, 22 | 12 | -20.00% | 110,656 | -15.16% | 0.61% | 116.38% | 5 | -28.57% | 2 | 100.00% |
| 30 Jun, 22 | 15 | -11.76% | 130,428 | -70.97% | 0.73% | 11.40% | 7 | 75.00% | 1 | -83.33% |
| 31 Mar, 22 | 17 | 13.33% | 449,213 | -57.27% | 2.52% | 8.72% | 4 | 100.00% | 6 | - |
| 31 Dec, 21 | 15 | -6.25% | 1,051,180 | -8.64% | 5.38% | 12.46% | 2 | -60.00% | 6 | - |
| 30 Sep, 21 | 16 | -11.11% | 1,150,614 | 50.88% | 6.57% | 43.15% | 5 | -37.50% | 6 | 50.00% |
| 30 Jun, 21 | 18 | 5.88% | 762,616 | 31.42% | 3.90% | 34.99% | 8 | -20.00% | 4 | - |
| 31 Mar, 21 | 17 | 21.43% | 580,296 | -46.61% | 3.34% | 3.74% | 10 | -28.57% | 4 | - |
| 31 Dec, 20 | 14 | - | 1,086,957 | - | 9.45% | - | 14 | - | - | - |
Purple Biotech Peer Ownership
| Ticker | Company |
|---|---|
| SLNO | Soleno Therapeutics, Inc. |
| PMVP | PMV Pharmaceuticals, Inc. |
| ARDS | Aridis Pharmaceuticals, Inc. |
| MNPR | Monopar Therapeutics Inc. |
| PLUR | Pluri Inc. |
| SABS | SAB Biotherapeutics, Inc. |
| BPTH | Bio-Path Holdings, Inc. |
| CVKD | Cadrenal Therapeutics, Inc. Common Stock |
| BLRX | BioLineRx Ltd. |
| CING | Cingulate Inc. |
| ANEB | Anebulo Pharmaceuticals, Inc. |
| BNOX | Bionomics Limited |
| ENLV | Enlivex Therapeutics Ltd. |
PPBT Ownership FAQ
Who Owns Purple Biotech?
Purple Biotech is owned by institutional shareholders (0.98%), insiders (3.27%), and public (95.75%). The largest institutional shareholder of Purple Biotech is ARMISTICE CAPITAL, LLC (5.24% of total shares) and the top mutual fund owner is Ark ETF Trust (0.01% of total shares).
Who are the major institutional shareholders of Purple Biotech?
Purple Biotech's major institutional shareholders are ARMISTICE CAPITAL, LLC, KINGSWOOD WEALTH ADVISORS, LLC, MORGAN STANLEY, VENTURE VISIONARY PARTNERS LLC, and VIRTU FINANCIAL LLC. The top five shareholders own together 6.98% of the company's share outstanding.
How many Purple Biotech shareholders are there?
As of Jun 2024, there are 9 institutional shareholders of Purple Biotech.
What percentage of Purple Biotech is owned by ARMISTICE CAPITAL, LLC?
ARMISTICE CAPITAL, LLC owns 1.36M shares of Purple Biotech, representing 5.24% of the company's total shares outstanding, valued at $552.71K (as of Jun 2024).
What percentage of Purple Biotech is owned by KINGSWOOD WEALTH ADVISORS, LLC?
As of Jun 2024, KINGSWOOD WEALTH ADVISORS, LLC holds 208.06K shares of Purple Biotech (PPBT), compromising 0.80% of the company, valued at $84.68K.
What percentage of Purple Biotech is owned by MORGAN STANLEY?
MORGAN STANLEY is the third largest holder of Purple Biotech. The company owns 203K of the company's shares outstanding (worth $82.62K).